Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,821,220
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
4,852,401
-
Shares change
-
-14,760
-
Total reported value, excl. options
-
$66,866,000
-
Value change
-
-$203,430
-
Number of buys
-
1
-
Number of sells
-
2
-
Price
-
$13.78
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q2 2021
As of 30 Jun 2021 Nanobiotix S.A. - Common Stock (NBTX) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,852,401 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, PERCEPTIVE ADVISORS LLC, Artal Group S.A., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, ORBIMED ADVISORS LLC, Woodline Partners LP, UBS Group AG, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, and Activest Wealth Management.
This table shows 10 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.